 | Up a level |
Jenal, M; Batliner, J; Reddy, V A; Haferlach, T; Tobler, A; Fey, M F; Torbett, B E; Tschan, M P (2010). The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia, 24(5), pp. 1073-6. Basingstoke: Nature Publishing Group 10.1038/leu.2010.26
Béné, M C; Nebe, T; Bettelheim, P; Buldini, B; Bumbea, H; Kern, W; Lacombe, F; Lemez, P; Marinov, I; Matutes, E; Maynadié, M; Oelschlagel, U; Orfao, A; Schabath, R; Solenthaler, M; Tschurtschenthaler, G; Vladareanu, A M; Zini, G; Faure, G C and Porwit, A (2011). Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia, 25(4), pp. 567-74. Basingstoke: Nature Publishing Group 10.1038/leu.2010.312
Metzelder, S K; Schroeder, T; Finck, A; Scholl, S; Fey, M; Götze, K; Linn, Y C; Kröger, M; Reiter, A; Salih, H R; Heinicke, T; Stuhlmann, R; Müller, L; Giagounidis, A; Meyer, R G; Brugger, W; Vöhringer, M; Dreger, P; Mori, M; Basara, N; ... (2012). High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia, 26(11), pp. 2353-2359. Basingstoke: Nature Publishing Group 10.1038/leu.2012.105
Hanfstein, B; Müller, M C; Hehlmann, R; Erben, P; Lauseker, M; Fabarius, A; Schnittger, S; Haferlach, C; Göhring, G; Proetel, U; Kolb, H-J; Krause, S W; Hofmann, W-K; Schubert, J; Einsele, H; Dengler, J; Hänel, M; Falge, C; Kanz, L; Neubauer, A; ... (2012). Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia, 26(9), pp. 2096-102. Basingstoke: Nature Publishing Group 10.1038/leu.2012.85
Grasedieck, S; Schöler, N; Bommer, M; Niess, J H; Tumani, H; Rouhi, A; Bloehdorn, J; Liebisch, P; Mertens, D; Döhner, H; Buske, C; Langer, C; Kuchenbauer, Florian (2012). Impact of serum storage conditions on microRNA stability. Leukemia, 26(11), pp. 2414-6. Basingstoke: Nature Publishing Group 10.1038/leu.2012.106
de Botton, S; Sanz, MA; Chevret, S; Dombret, H; Martin, G; Thomas, X; Mediavilla, JD; Recher, C; Ades, L; Quesnel, B; Brault, P; Fey, M; Wandt, H; Machover, D; Guerci, A; Maloisel, F; Stoppa, AM; Rayon, C; Ribera, JM; Chomienne, C; ... (2006). Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia, 20(1), pp. 35-41. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404006
Tschan, M P; Gullberg, U; Shan, D; Torbett, B E; Fey, M F; Tobler, A (2007). The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. Leukemia, 22(5), pp. 1087-1090. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2405018
Röth, A; Dürig, J; Himmelreich, H; Bug, S; Siebert, R; Dührsen, U; Lansdorp, P M; Baerlocher, G M (2007). Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia. Leukemia, 21(12), pp. 2456-62. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404968
Mühlemann, K; Wenger, C; Zenhäusern, R; Täuber, MG (2005). Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia, 19(4), pp. 545-50. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2403674
Hirt, A; Schmid, A M; Julmy, F; Schmitz, N M R; Leibundgut, K (2009). Expression of cyclin A in childhood acute lymphoblastic leukemia cells reveals undisturbed G1-S phase transition and passage through the S phase. Leukemia, 23(2), pp. 414-7. Basingstoke: Nature Publishing Group 10.1038/leu.2008.200
Christ, E; Linka, A; Jacky, E; Speich, R; Marincek, B; Schaffner, A (1996). Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia, 10(4), pp. 731-4. Basingstoke: Nature Publishing Group
Nicolae, Alina; Xi, L; Pittaluga, S; Abdullaev, Z; Pack, S D; Chen, J; Waldmann, T A; Jaffe, E S; Raffeld, M (2014). Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas. Leukemia, 28(11), pp. 2244-2248. Nature Publishing Group 10.1038/leu.2014.200
Pastor, V; Hirabayashi, S; Karow, Axel; Wehrle, J; Kozyra, E J; Nienhold, R; Ruzaike, G; Lebrecht, D; Yoshimi, A; Niewisch, M; Ripperger, T; Göhring, G; Baumann, I; Schwarz, S; Strahm, B; Flotho, C; Skoda, R C; Niemeyer, C M; Wlodarski, M W (2017). Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia, 31(3), pp. 759-762. Nature Publishing Group 10.1038/leu.2016.342
Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Cross, N C P; White, H E; Colomer, D; Ehrencrona, H; Foroni, L; Gottardi, E; Lange, T; Lion, T; Machova Polakova, K; Dulucq, S; Martinelli, G; Oppliger Leibundgut, Elisabeth; Pallisgaard, N; Barbany, G; Sacha, T; Talmaci, R; Izzo, B; Saglio, G; Pane, F; Müller, M C; ... (2015). Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia, 29(5), pp. 999-1003. Nature Publishing Group 10.1038/leu.2015.29
Riether, Carsten; Gschwend, T; Huguenin, Anne-Laure; Schürch, Christian; Ochsenbein, Adrian (2015). Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells. Leukemia, 29(8), pp. 1781-1785. Nature Publishing Group 10.1038/leu.2015.26
Gratwohl, A; Pfirrmann, M; Zander, A; Kröger, N; Beelen, D; Novotny, J; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Sayer, H G; Falge, C; Bunjes, D; Döhner, H; Ganser, A; Schmidt-Wolf, I; Schwerdtfeger, R; Baurmann, H; Kuse, R; Schmitz, N; ... (2016). Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia, 30(3), pp. 562-569. Nature Publishing Group 10.1038/leu.2015.281
White, H; Deprez, L; Corbisier, P; Hall, V; Lin, F; Mazoua, S; Trapmann, S; Aggerholm, A; Andrikovics, H; Akiki, S; Barbany, G; Boeckx, N; Bench, A; Catherwood, M; Cayuela, J-M; Chudleigh, S; Clench, T; Colomer, D; Daraio, F; Dulucq, S; ... (2015). A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR. Leukemia, 29(2), pp. 369-376. Nature Publishing Group 10.1038/leu.2014.217
Miranda, M B; Lauseker, M; Kraus, M-P; Proetel, U; Hanfstein, B; Fabarius, A; Baerlocher, Gabriela M.; Heim, D; Hossfeld, D K; Kolb, H-J; Krause, S W; Nerl, C; Brümmendorf, T H; Verbeek, W; Fauser, A A; Prümmer, O; Neben, K; Hess, U; Mahlberg, R; Plöger, C; ... (2016). Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia, 30(6), pp. 1255-1262. Nature Publishing Group 10.1038/leu.2016.20
Zanotti, L; Angioni, R; Calì, B; Soldani, C; Ploia, C; Moalli, Federica; Gargesha, M; D'Amico, G; Elliman, S; Tedeschi, G; Maffioli, E; Negri, A; Zacchigna, S; Sarukhan, A; Stein, Jens Volker; Viola, A (2016). Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1. Leukemia, 30(5), pp. 1143-1154. Nature Publishing Group 10.1038/leu.2016.33
Hehlmann, R; Lauseker, M; Saußele, S; Pfirrmann, M; Krause, S; Kolb, H J; Neubauer, A; Hossfeld, D K; Nerl, C; Gratwohl, A; Baerlocher, Gabriela M.; Heim, D; Brümmendorf, T H; Fabarius, A; Haferlach, C; Schlegelberger, B; Müller, M C; Jeromin, S; Proetel, U; Kohlbrenner, K; ... (2017). Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants. Leukemia, 31(11), pp. 2398-2406. Nature Publishing Group 10.1038/leu.2017.253
Zander, T; Aebi, Stefan; Pabst, T; Renner, C; Driessen, C (2017). Spotlight on pomalidomide: could less be more? Leukemia, 31(9), pp. 1987-1989. Nature Publishing Group 10.1038/leu.2017.156
Radpour, Ramin; Riether, Carsten; Simillion, Cedric; Höpner, Sabine; Bruggmann, Rémy; Ochsenbein, Adrian (2019). CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia. Leukemia, 33(10), pp. 2379-2392. Nature Publishing Group 10.1038/s41375-019-0441-9
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Kalmanti, Lida; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Haferlach, Claudia; Schlegelberger, Brigitte; Fabarius, Alice; Seifarth, Wolfgang; Spieß, Birgit; Wuchter, Patrick; Krause, Stefan; Kolb, Hans-Jochem; Neubauer, Andreas; Hossfeld, Dieter K; Nerl, Christoph; Gratwohl, Alois; Baerlocher, Gabriela M.; ... (2020). High-risk additional chromosomal abnormalities at low blast counts herald death by CML. Leukemia, 34(8), pp. 2074-2086. Springer Nature 10.1038/s41375-020-0826-9
Rafiq, Sreoshee; McKenna, Sharon L; Muller, Sylviane; Tschan, Mario; Humbert, Magali (2021). Lysosomes in acute myeloid leukemia: potential therapeutic targets? Leukemia, 35(10), pp. 2759-2770. Springer Nature 10.1038/s41375-021-01388-x
Brkic, Sime; Stivala, Simona; Santopolo, Alice; Szybinski, Jakub; Jungius, Sarah; Passweg, Jakob R; Tsakiris, Dimitrios; Dirnhofer, Stefan; Hutter, Gregor; Leonards, Katharina; Lischer, Heidi E L; Dettmer, Matthias S; Neel, Benjamin G; Levine, Ross L; Meyer, Sara C (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia, 35(10), pp. 2875-2884. Springer Nature 10.1038/s41375-021-01391-2
Chatzikonstantinou, Thomas; Kapetanakis, Anargyros; Scarfò, Lydia; Karakatsoulis, Georgios; Allsup, David; Cabrero, Alejandro Alonso; Andres, Martin; Antic, Darko; Baile, Mónica; Baliakas, Panagiotis; Bron, Dominique; Capasso, Antonella; Chatzileontiadou, Sofia; Cordoba, Raul; Correa, Juan-Gonzalo; Cuéllar-García, Carolina; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Demosthenous, Christos; ... (2021). COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia, 35(12), pp. 3444-3454. Springer Nature 10.1038/s41375-021-01450-8
White, Helen E; Salmon, Matthew; Albano, Francesco; Andersen, Christina Søs Auður; Balabanov, Stefan; Balatzenko, Gueorgui; Barbany, Gisela; Cayuela, Jean-Michel; Cerveira, Nuno; Cochaux, Pascale; Colomer, Dolors; Coriu, Daniel; Diamond, Joana; Dietz, Christian; Dulucq, Stéphanie; Engvall, Marie; Franke, Georg N; Gineikiene-Valentine, Egle; Gniot, Michal; Gómez-Casares, María Teresa; ... (2022). Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia, 36(7), pp. 1834-1842. Springer Nature 10.1038/s41375-022-01607-z
Bührer, Elias D; Amrein, Michael A; Forster, Stefan; Isringhausen, Stephan; Schürch, Christian M; Bhate, Salil S; Brodie, Tess; Zindel, Joel; Stroka, Deborah; Al Sayed, Mohamad; Nombela-Arrieta, César; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian F (2022). Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance. Leukemia, 36(11), pp. 2634-2646. Springer Nature 10.1038/s41375-022-01682-2
Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner Agocs, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rüfer, Axel; Renner, Christoph; Driessen, Christoph (2023). Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia, 37(3), pp. 699-701. Springer Nature 10.1038/s41375-023-01809-z
Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J; Topp, Max S; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M; Keller, Ulrich Bernd; Krause, Stefan W; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; ... (2024). Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia, 38(1), pp. 160-167. Springer Nature 10.1038/s41375-023-02064-y
Mandhair, Harpreet K; Radpour, Ramin; Westerhuis, Mira; Banz, Yara; Humbert, Magali; Arambasic, Miroslav; Dengjel, Jörn; Davies, Andrew; Tschan, Mario P; Novak, Urban (2024). Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia, 38(2), pp. 424-429. Nature Publishing Group 10.1038/s41375-024-02147-4
Walter, R B; Othus, M; Burnett, A K; Löwenberg, B; Kantarjian, H M; Ossenkoppele, G J; Hills, R K; Ravandi, F; Pabst, Thomas; Evans, A; Pierce, S R; Vekemans, M-C; Appelbaum, F R; Estey, E H (2014). Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia, 29(2), pp. 312-320. Nature Publishing Group 10.1038/leu.2014.242
Cornelissen, J J; Versluis, J; Passweg, Jakob; van Putten, W L J; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J M; van Marwijk Kooy, M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M-C; Breems, D A; Verdonck, L F; Fey, Martin; Jongen-Lavrencic, M; Janssen, J J W M; Huls, G; Kuball, J; ... (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), pp. 1041-1050. Nature Publishing Group 10.1038/leu.2014.332
Hanfstein, B; Shlyakhto, V; Lauseker, M; Hehlmann, R; Saussele, S; Dietz, C; Erben, P; Fabarius, A; Proetel, U; Schnittger, S; Krause, S W; Schubert, J; Einsele, H; Hänel, M; Dengler, J; Falge, C; Kanz, L; Neubauer, A; Kneba, M; Stegelmann, F; ... (2014). Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. Leukemia, 28(10), pp. 1988-1992. Nature Publishing Group 10.1038/leu.2014.153
Kalmanti, L; Saussele, S; Lauseker, M; Müller, M C; Dietz, C T; Heinrich, L; Hanfstein, B; Proetel, U; Fabarius, A; Krause, S W; Rinaldetti, S; Dengler, J; Falge, C; Oppliger Leibundgut, Elisabeth; Burchert, A; Neubauer, A; Kanz, L; Stegelmann, F; Pfreundschuh, M; Spiekermann, K; ... (2015). Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV. Leukemia, 29(5), pp. 1123-1132. Nature Publishing Group 10.1038/leu.2015.36
Fernandez Marrero, Yuniel; Spinner, S; Jost, P J; Kaufmann, Thomas (2016). Survival control of malignant lymphocytes by anti-apoptotic MCL-1. Leukemia, 30(11), pp. 2152-2159. Nature Publishing Group 10.1038/leu.2016.213
Versluis, J; In 't Hout, F E M; Devillier, R; van Putten, W L J; Manz, M G; Vekemans, M-C; Legdeur, M-C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J M; van der Reijden, B A; Meloni, G; Schouten, H C; Vellenga, E; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; ... (2017). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1), pp. 26-33. Nature Publishing Group 10.1038/leu.2016.183
Leich, E; Hoster, E; Wartenberg, Martin; Unterhalt, M; Siebert, R; Koch, K; Klapper, W; Engelhard, M; Puppe, B; Horn, H; Staiger, A M; Stuhlmann-Laeisz, C; Bernd, H W; Feller, A C; Hummel, M; Lenze, D; Stein, H; Hartmann, S; Hansmann, M L; Möller, P; ... (2016). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia, 30(4), pp. 854-860. Nature Publishing Group 10.1038/leu.2015.330
Horn, H; Ziepert, M; Wartenberg, Martin; Staiger, A M; Barth, T F E; Bernd, H-W; Feller, A C; Klapper, W; Stuhlmann-Laeisz, C; Hummel, M; Stein, H; Lenze, D; Hartmann, S; Hansmann, M-L; Möller, P; Cogliatti, S; Pfreundschuh, M; Trümper, L; Loeffler, M; Glass, B; ... (2015). Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. Leukemia, 29(7), pp. 1564-1570. Nature Publishing Group 10.1038/leu.2015.43
McCracken, A N; McMonigle, R J; Tessier, J; Fransson, R; Perryman, M S; Chen, B; Keebaugh, A; Selwan, E; Barr, S A; Kim, S M; Roy, S G; Liu, G; Fallegger, D; Sernissi, L; Brandt, C; Moitessier, N; Snider, A J; Clare, S; Müschen, M; Huwiler, Andrea; ... (2017). Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia, 31(3), pp. 669-677. Nature Publishing Group 10.1038/leu.2016.244
Nicolae, Alina; Xi, L; Pham, T H; Pham, T-A; Navarro, W; Meeker, H G; Pittaluga, S; Jaffe, E S; Raffeld, M (2016). Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia, 30(11), pp. 2245-2247. Nature Publishing Group 10.1038/leu.2016.178
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W; Hofmann, Wolf-Karsten; Hasford, Joerg; ... (2018). Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV. Leukemia, 32(5), pp. 1222-1228. Nature Publishing Group 10.1038/s41375-018-0055-7
Engel, Nicole; Rovó, Alicia; Badoglio, Manuela; Labopin, Myriam; Basak, Grzegorz W; Beguin, Yves; Guyotat, Denis; Ljungman, Per; Nagler, Arnon; Schattenberg, Anton; Schroeder, Thomas; Schroyens, Wilfried; Tischer, Johanna; Socie, Gerard; Kolb, Hans-Jochem; Tichelli, Andre; Salooja, Nina; Duarte, Rafael F (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33(2), pp. 508-517. Nature Publishing Group 10.1038/s41375-018-0218-6
Zeijlemaker, Wendelien; Grob, Tim; Meijer, Rosa; Hanekamp, Diana; Kelder, Angèle; Carbaat-Ham, Jannemieke C; Oussoren-Brockhoff, Yvonne J M; Snel, Alexander N; Veldhuizen, Dennis; Scholten, Willemijn J; Maertens, Johan; Breems, Dimitri A; Pabst Müller, Thomas Niklaus; Manz, Markus G; van der Velden, Vincent H J; Slomp, Jennichjen; Preijers, Frank; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Löwenberg, Bob; ... (2019). CD34CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia, 33(5), pp. 1102-1112. Nature Publishing Group 10.1038/s41375-018-0326-3
Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; A von dem Borne, P; Chalandon, Y; Cloos, J; Deeren, D; Fehr, M; Gjertsen, B; Graux, C; Huls, G; Janssen, J J J W; Jaspers, A; Jongen-Lavrencic, M; de Jongh, E; Klein, S K; van der Klift, M; ... (2020). Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, 34(7), pp. 1751-1759. Nature Publishing Group 10.1038/s41375-020-0725-0
Scarfò, Lydia; Chatzikonstantinou, Thomas; Rigolin, Gian Matteo; Quaresmini, Giulia; Motta, Marina; Vitale, Candida; Garcia-Marco, Jose Antonio; Hernández-Rivas, José Ángel; Mirás, Fatima; Baile, Mónica; Marquet, Juan; Niemann, Carsten U; Reda, Gianluigi; Munir, Talha; Gimeno, Eva; Marchetti, Monia; Quaglia, Francesca Maria; Varettoni, Marzia; Delgado, Julio; Iyengar, Sunil; ... (2020). COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia, 34(9), pp. 2354-2363. Nature Publishing Group 10.1038/s41375-020-0959-x
Janssen, J J W M; Löwenberg, B; Manz, M; Biemond, B J; Westerweel, P E; Klein, S K; Fehr, M; Sinnige, H A M; Efthymiou, A; Legdeur, M C J C; Pabst, T; Gregor, M; van der Poel, M W M; Deeren, D; Tick, L W; Jongen-Lavrencic, M; van Obbergh, F; Boersma, R S; de Weerdt, O; Chalandon, Y; ... (2022). Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia, 36(9), pp. 2189-2195. Nature Publishing Group 10.1038/s41375-022-01657-3
Boyiadzis, Michael; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Battiwalla, Minoo; Bejanyan, Nelli; Bhatt, Vijaya Raj; Brown, Valerie I; Castillo, Paul; Cerny, Jan; Copelan, Edward A; Craddock, Charles; Dholaria, Bhagirathbhai; Perez, Miguel Angel Diaz; Ebens, Christen L; ... (2023). Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia, 37(5), pp. 1006-1017. Springer Nature 10.1038/s41375-022-01738-3
Boyiadzis, Michael; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Battiwalla, Minoo; Bejanyan, Nelli; Bhatt, Vijaya Raj; Brown, Valerie I; Castillo, Paul; Cerny, Jan; Copelan, Edward A; Craddock, Charles; Dholaria, Bhagirathbhai; Perez, Miguel Angel Diaz; Ebens, Christen L; ... (2023). Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia, 37(5), p. 1173. Springer Nature 10.1038/s41375-023-01814-2
Klyuchnikov, Evgeny; Badbaran, Anita; Massoud, Radwan; Freiberger, Petra; Wolschke, Christine; Ayuk, Francis; Fehse, Boris; Bacher, Ulrike; Kröger, Nicolaus (2024). Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR. Leukemia, 38(2), pp. 386-388. Nature Publishing Group 10.1038/s41375-024-02148-3
Wang, Trent P; Ahn, Kwang W; Shadman, Mazyar; Kaur, Manmeet; Ahmed, Nausheen; Bacher, Vera; Cerny, Jan; Chen, Andy; Epperla, Narendranath; Frigault, Matthew; Grover, Natalie; Haverkos, Bradley; Hill, Brian; Hossain, Nasheed; Iqbal, Madiha; Jain, Tania; Krem, Maxwell M; Maakaron, Joseph; Modi, Dipenkumar; Alhaj Moustafa, Muhamad; ... (2024). Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia, 38(7), pp. 1564-1569. Springer Nature 10.1038/s41375-024-02242-6
